Survival rates for men with metastatic prostate cancer have increased by an average of six months, something which coincides with the gradual introduction of ‘dual treatment’ since 2016. This is according to a register study of all Swedish men diagnosed between 2008 and 2020. The results are published in the medical journal JAMA Network Open. … Read more
People with intermediate risk, localized prostate cancer can be treated as effectively using fewer and higher doses of radiation therapy delivered over five treatment sessions as they can with lower doses delivered over several weeks, a new phase III randomized trial suggests. The findings, which are the latest from a series of studies investigating the … Read more
Patients could see treatment sessions cut from 20 to five, with high success rate Higher doses of radiotherapy can slash prostate cancer treatment time by as much as 75 per cent, a ‘game-changing’ study has found. Suitable patients could see the number of treatment sessions they need cut from 20 to five, with a 96 … Read more
Effective treatment for lower urinary tract symptoms (LUTS) in men aged 50 or older is associated with a lower risk of death over the next few years reports a study in the October issue of The Journal of Urology®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott … Read more
Louis van Gaal is waiting to find out if recent cancer surgery has been successful The former Man United and Netherlands manager is battling prostate cancer Van Gaal previously revealed he had undergone 25 radiation procedures Louis van Gaal has revealed he will find out whether his recent cancer operation has been successful in treating … Read more
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has issued a new consensus statement to provide standardized guidance for the selection and management of metastatic castrate-resistant prostate cancer (mCRPC) patients being treated with 177Lu-PSMA radionuclide therapy. The statement, published in the July issue of The Journal of Nuclear Medicine, also reviews current clinical struggles … Read more